BMY Income Statement

Bristol-Myers Squibb Company - Revenue, Expenses & Profit Analysis

Stock Price

$58.19

Market Cap

$95.36B

P/E Ratio

17.5

Most Recent Quarter

Period: FY(2025-12-31)

Revenue

Total sales from operations

$48.19B

-0.2% YoY

Cost of Revenue

Direct costs of sales

$13.94B

Gross Profit

Revenue - Cost of Revenue

$34.26B

Net Income

Bottom line profit

$7.05B

Earnings Per Share (Diluted)

Net income per share

$3.46

Profitability Metrics

Historical Income Statements

PeriodRevenueGross ProfitOperating IncomeNet IncomeEPS
FY$48.19B$34.26B-$7.05B$3.46
FY$48.30B$34.33B-$-8.95B$-4.41
FY$45.01B$34.31B-$8.03B$3.86
FY$46.16B$36.02B-$6.33B$2.95
FY$46.38B$36.45B-$6.99B$3.12

View Complete Financial Analysis

Full income statements, balance sheets, cash flows, and AI-powered insights

Open Full Analysis

Frequently Asked Questions

What is BMY's revenue?

BMY's most recent quarterly revenue was $48.19B, representing a decline of 0.2% year-over-year.

Is BMY profitable?

BMY reported a profit of $7.05B in the most recent quarter.

What is BMY's operating income?

Operating income data is available in the income statement.

What is BMY's earnings per share (EPS)?

BMY reported diluted earnings per share of $3.46 in the most recent quarter.

What is BMY's gross profit margin?

Gross margin data is available in the profitability metrics section.

Explore Categories